FDA Panel Reiterates the Cancer Risks of Talc
Go back to FDA Panel Reiterates the Cancer Risks of Talc| Johnson & Johnson (NYSE: JNJ) | Delayed: 259.24 +2.26 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $256.98 | 52 Week High | $126.07 | |||
| Open | $255.89 | 52 Week Low | $94.28 | |||
| Day High | $259.60 | P/E | 53.90 | |||
| Day Low | $255.12 | EPS | $4.81 | |||
| Volume | 6,533,644 | |||||
